Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: Potential involvement of oxysterols

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 3, 2009, Pages

  Ferré, Natàlia ^a   Martínez Clemente, Marcos ^a   López Parra, Marta ^a   González Périz, Ana ^a   Horrillo, Raquel ^a   Planagumà, Anna ^a   Camps, Jordi ^b   Joven, Jorge ^b   Tres, Alba ^a   Guardiola, Francesc ^a   Bataller, Ramón ^a   Arroyo, Vicente ^a   Clària, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Apolipoprotein E; Cholesterol oxidized products; Hypercholesterolemia; Liver cells

Indexed keywords

4 HYDROXYNONENAL; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYTOCHROME P450; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPID PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYSTEROL; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; CCL2 PROTEIN, MOUSE; CHOLESTEROL; CHOLESTEROL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FATTY LIVER; HEPATITIS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER INJURY; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN SECRETION; STELLATE CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; GENETIC PREDISPOSITION; GENETICS; ITO CELL; LIVER DISEASE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION;

ANIMALS; APOLIPOPROTEINS E; CARBON TETRACHLORIDE; CHEMOKINE CCL2; CHOLESTEROL; GENETIC PREDISPOSITION TO DISEASE; HEPATIC STELLATE CELLS; HYDROXYCHOLESTEROLS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-8; LIVER DISEASES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NF-KAPPA B; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 65349093477     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00547.2007     Document Type: Article

References (42)

1. Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol 31: 17-24, 1999.
2. Ando M, Tomoyori H, Imaizumi K. Dietary cholesterol-oxidation products accumulate in serum and liver in apolipoprotein E-deficient mice, but do not accelerate atherosclerosis. Br J Nutr 88: 339-345, 2002.
3. Ares MP, Kallin B, Eriksson P, Nilsson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15: 1584-1590, 1995.
4. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 250: 91-104, 2001.
5. Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 278: 35755-35766, 2003.
6. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 115: 209-218, 2005.
7. Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-1156, 2000.
8. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142: 1-28, 1999.
9. Buyssens N, Kockx MM, Herman AG, Lazou JM, Van den Berg K, Wisse E, Geerts A. Centrolobular liver fibrosis in the hypercholesterolemic rabbit. Hepatology 24: 939-946, 1996.
10. Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE, Gentilini P, Marra F. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 33: 713-721, 2001.
11. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10: 927-939, 2005.
12. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112, 2006.
13. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250, 2000.
14. González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J, Clària J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 20: 2537-2539, 2006.
15. Grau A, Codony R, Grimpa S, Baucells MD, Guardiola F. Cholesterol oxidation in frozen dark chicken meat: influence of dietary fat source, and α-tocopherol and ascorbic acid supplementation. Meat Sci 57: 197-208, 2001.
16. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-d807, 2002.
17. Guardiola F, Codony R, Rafecas M, Boatella J. Comparison of three methods for the determination of oxysterols in spray-dried egg. J Chromatogr A 705: 289-304, 1995.
18. Hua J, Qiu de K, Li JQ, Li EL, Chen XY, Peng YS. Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 22: 862-869, 2007.
19. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102: 538-549, 1998.
20. Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290: G1083-G1088, 2006.
21. Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology 38: 1178-1187, 2003.
22. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 28: 370-379, 2008.
23. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
24. Leonarduzzi G, Sevanian A, Sottero B, Canan Arkan M, Biasi F, Chiarpotto E, Basaga H, Poli G. Up-regulation of the profibrogenic cytokine TGF-β1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J 15: 1619-1621, 2001.
25. Leonarduzzi G, Gamba P, Sottero B, Kadl A, Robbesyn F, Calogero RA, Biasi F, Chiarpotto E, Leitinger N, Sevanian A, Poli G. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 39: 1152-1161, 2005.
26. Ludewing B, Jaggi M, Dumrese T, Brduscha-Riem K, Odermatt B, Hengartner H, Zinkernagel RM. Hypercholesterolemia exacerbates virus-induced immunologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 166: 3369-3376, 2001.
27. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 92: 1674-1680, 1993.
28. Masumoto T, Ohkubo K, Yamamoto K, Ninomiya T, Abe M, Akbar SM, Michitaka K, Horiike N, Onji M. Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. Hepatogastroenterology 45: 1630-1634, 1998.
29. McIntyre M, Benhamou JP, Bircher J, Rizzeto M, Rodés J. Oxford Textbook of Clinical Hepatology. Oxford, UK: Oxford University Press, 1999.
30. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 282: 1523-1539, 1999.
31. Ohlsson BG, Englund MC, Karlsson AL, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest 98: 78-89, 1996.
32. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I, Amato F, Cotichini R, Stroffolini T, Mele A, Collaborating Group ACE. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 41: 1151-1159, 2005.
33. Planagumà A, Clària J, Miquel R, López-Parra M, Titos E, Masferrer JL, Arroyo V, Rodés J. Inhibition of COX-2 reduces liver fibrosis by mechanisms involving Kupffer cell apoptosis and PPAR activation. FASEB J 19: 1120-1122, 2005.
34. Schwabe R, Schnabl B, Kweon YO, Brenner DA. CD-40 activates NF-κB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 166: 6812-6819, 2001.
35. Titos E, Clària J, Bataller R, Bosch-Marcé M, Ginès P, Jiménez W, Arroyo V, Rivera F, Rodés J. Hepatocyte-derived cysteinil leukotrienes modulate vascular tone in experimental cirrhosis. Gastroenterology 119: 794-805, 2000.
36. Tous M, Ferré N, Camps J, Riu F, Joven J. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem 268: 53-58, 2005.
37. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 101: 17813-17818, 2004.
38. Varedi M, Ghahary A, Scott PG, Tredget EE. Cytoskeleton regulates expression of genes for transforming growth factor-beta 1 and extracellular matrix proteins in dermal fibroblasts. J Cell Physiol 172: 192-199, 1997.
39. Yang L, Magness ST, Bataller R, Rippe RA, Brenner DA. NF-kappaB activation in Kupffer cells after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 289: G530-G538, 2005.
40. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32: 1248-1254, 2000.
41. Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, Novo E, Bertolani C, Milani S, Vizzutti F, Vercelli A, Pinzani M, Laffi G, LaVilla G, Parola M, Marra F. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol 46: 230-238, 2007.
42. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992.